It has been about a month since the last earnings report for Masimo (
MASI Quick Quote MASI - Free Report) . Shares have added about 6% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Masimo due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
Masimo's Q2 Earnings Surpass Estimates, '21 View Up
Masimo delivered adjusted earnings per share of 94 cents in the second quarter of 2021, up 10.6% year over year. The figure surpassed the Zacks Consensus Estimate by 3.3%.
The adjustments include acquisition, integration and related costs, and litigation related expenses, settlements and awards, among others.
GAAP earnings per share for the quarter was 88 cents a share, down by 8.3% from the year-earlier figure.
Revenues in Detail
Masimo registered revenues of $305.1 million in the second quarter, up 1.4% year over year on a reported basis. The figure also surpassed the Zacks Consensus Estimate by 2.9%.
However, at constant exchange rate (CER), revenues declined by 0.1%.
Per management, shipments of non-invasive technology boards and instruments, excluding handheld and fingertip pulse oximeters, were 72,500 in the second quarter of 2021. The company also recorded a strong rebound in sensor sales.
In the quarter under review, Masimo’s gross profit rose 0.7% to $192.9 million. Gross margin contracted 43 basis points (bps) to 63.2%.
Selling, general & administrative expenses declined 4.7% to $93.8 million. Research and development expenses went up 9.9% year over year to $33.9 million. Adjusted operating expenses of $127.8 million decreased 1.2% year over year.
Adjusted operating profit totaled $65.1 million, reflecting a 4.6% uptick from the prior-year quarter. Adjusted operating margin in the second quarter expanded by 67 bps to 21.3%.
Masimo exited the second quarter of 2021 with cash and cash equivalents of $575.9 million compared with $551.9 million at the end of the first quarter.
Cumulative net cash flow from operating activities at the end of the second quarter was $85.3 million compared with $106.1 million a year ago.
Masimo has updated its earlier-provided full-year 2021 financial outlook.
Total revenues are now projected at $1,216 million, reflecting reported growth of 6.3% and CER growth of 5.4%. This is up from the previous view of $1,205 million, which reflected an uptick of 5.4% and 4.5% on reported and CER basis, respectively. The Zacks Consensus Estimate for the metric is currently pegged at $1.20 billion.
Adjusted earnings per share is projected at $3.85, up from the previous outlook of $3.83. The Zacks Consensus Estimate for the same is pegged at $3.83.
How Have Estimates Been Moving Since Then?
It turns out, estimates revision have trended downward during the past month.
Currently, Masimo has a subpar Growth Score of D, a grade with the same score on the momentum front. Following the exact same course, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Masimo has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.